[1] |
. Bolster JM et al. Eur J Nucl Med. 1986; 12:321-324.
|
[2] |
. Tisljar U et al. J Nucl Med,1979;20:973-975.
|
[3] |
. Kloss GfLeven M. Eur J Nucl Med,1979;4:179-181.
|
[4] |
. Bubeck B et al. Eur J Nucl Med,1981; 6:227-230.
|
[5] |
. Kawai K et al. J Nucl Med,1991; 32:819-823.
|
[6] |
. Kloster,Int J Nucl Med Biol,1982;9:259-262.
|
[7] |
. Kawai K et al. J Nucl Med,1988;29:778(abstract).
|
[8] |
. Oldendorf WH. Brain Res,1970; 24:372-375.
|
[9] |
. Oldendorf WH. Am J Physiol,1971;221:1629-1639.
|
[10] |
. Copper JR et al. In:The biochemical basis of nueropharmacology. Filth edition. New York:Ox ford University Pressl 1986:203.
|
[11] |
. Mimnaugh MN,Gearien. In:Foye Wo(eds),Princi-ples of medicinal chemistry. Third edition. Philadel phia:Lea&Febige 1989:343.
|
[12] |
. Langen K J et al. J Nucl Med,1990; 31:281:284.
|
[13] |
. Meyer GJ. Eur J Nucl Med,1985;10:373-375.
|
[14] |
. Biersack HJ et al. J Nucl Med,1989; 30:110-114.
|
[15] |
. Langen KJ et al. J Nucl Med,1991; 32:1225-1228.
|
[16] |
. Pardrige WH et al. J Neurochem,1977;28:103-106.
|
[17] |
. Bergstrom M et al. J Compul Assist Tomogr,1987;11:208-210.
|
[18] |
. Pardridge WM. Phys Rev,1983; 63:1481-1482.
|
[19] |
. Oldendorf WH. J Nucl Med,1991; 32:1229(editorial).
|
[20] |
. Ell PJ et al. J Nucl Med,1991; 32:2193(Getter).
|
[21] |
. Langtin KJ et al. J Nucl Med,1991;32:2193(reply).
|
[22] |
. Guth-Tougelides et al. J Nucl Med,1990;1:766.
|